Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAF<sup>V600E</sup> Mutation Showed a Complete Metabolic Response to PD-1 Blockade and Bevacizumab: A Case Report. This evidence concerns the gene BRAF and colorectal cancer.